Treatment of cancer with allogeneic natural killer (NK) cell therapies has seen rapid
development, especially use against hematologic malignancies. Clinical trials of NK cell …

Cell therapy is emerging as a very promising therapeutic modality against cancer,
spearheaded by the clinical success of chimeric antigen receptor (CAR) modified T cells for …

Engineered natural killer cells expressing chimeric antigen receptors (CAR)—a promising
approach in tumor immunotherapy - Neuber - Biotarget Have a website account?Log In orRegister …

Background Natural killer (NK) cells have efficient intrinsic recognition capabilities toward
abnormal cells. This fact makes them particularly attractive as safe effector cells for cancer …

EP3240551A4 - Methods of treating hematological disorders, solid tumors, or infectious
diseases using natural killer cells - Google Patents EP3240551A4 - Methods of treating …

2020-05-29 Assigned to FATE THERAPEUTICS, INC. reassignment FATE THERAPEUTICS,
INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS) …

Background & Aim Human induced pluripotent stem cells (iPSCs) are emerging as a potent
starting material for allogeneic cell therapies. As a prerequisite, we have established a GMP …

T cells are potentially curative for patients with metastatic cancer, but many patients with
cancer have T cells that are'terminally differentiated', a condition associated with treatment …

Figure 1: Linear model of NK cell development. NK cells share the common lymphoid
progenitor with B cells, T cells and innate lymphoid cells (ILC). Acquisition of IL2RB/CD122 …

Natural killer (NK) cells are the main innate immune cells, and have powerful antitumor
activity in vitro, but NK cells based immunotherapy does not often get satisfactory results in …